A Placebo-Controlled, Blinded and Randomised Study on the Effects of Recombinant Human Thyrotropin on Quality of Life in the Treatment of Thyroid Cancer

Birte Nygaard; Lars Bastholt; Finn Noe Bennedbæk; Tobias Wirenfeldt Klausen

doi:10.1159/000354803

A Placebo-Controlled, Blinded and Randomised Study on the Effects of Recombinant Human Thyrotropin on Quality of Life in the Treatment of Thyroid Cancer

Birte Nygaard, Lars Bastholt, Finn Noe Bennedbæk, Tobias Wirenfeldt Klausen

Department of Clinical Medicine

Original language	English
Journal	European Thyroid Journal
Volume	2
Issue number	3
Pages (from-to)	195-202
Number of pages	8
ISSN	2235-0640
DOIs	https://doi.org/10.1159/000354803
Publication status	Published - 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1159/000354803

Cite this

@article{ef5aef045ba64ff1a97f9ede573003ff,

title = "A Placebo-Controlled, Blinded and Randomised Study on the Effects of Recombinant Human Thyrotropin on Quality of Life in the Treatment of Thyroid Cancer",

author = "Birte Nygaard and Lars Bastholt and Bennedb{\ae}k, {Finn Noe} and Klausen, {Tobias Wirenfeldt}",

year = "2013",

doi = "10.1159/000354803",

language = "English",

volume = "2",

pages = "195--202",

journal = "European Thyroid Journal",

issn = "2235-0640",

publisher = "S Karger AG",

number = "3",

}

TY - JOUR

T1 - A Placebo-Controlled, Blinded and Randomised Study on the Effects of Recombinant Human Thyrotropin on Quality of Life in the Treatment of Thyroid Cancer

AU - Nygaard, Birte

AU - Bastholt, Lars

AU - Bennedbæk, Finn Noe

AU - Klausen, Tobias Wirenfeldt

PY - 2013

Y1 - 2013

U2 - 10.1159/000354803

DO - 10.1159/000354803

M3 - Journal article

C2 - 24847453

SN - 2235-0640

VL - 2

SP - 195

EP - 202

JO - European Thyroid Journal

JF - European Thyroid Journal

IS - 3

ER -